Ayurvedic and other herbal medicines are going to ban across Europe, from May first 2011 onwards. This is of there is no license. Ayurvedic and traditional herbal medicines will need to be licensed with the “EU directive passed in 2004” its compulsory, which takes effect from May first 2011.
Any drug which is going to be marketed in the European Union or the U.S.A., has to undergo extensive studies related to the results of physical chemical, biological or microbiological tests as well as pharmacological and toxicological tests and clinical trials carried out on the product. The Ayurvedic medicines are safe from side-effects, being 100% if it is Ayurvedic.
Official sources said those ayurvedic products marketed before the legislation came into force in 2004 can continue to market their product until April 30, 2011, under the transitional measures.
Once this has expired, all herbal medicinal products must have prior authorisation before they can be marketed in the EU. Ayurvedic medicines such as ‘ashwagandha’ will not be available for sale across Europe from may first.
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued more than a dozen safety alerts in the past two years, including one over aristolochia, a banned toxic plant derivative, which reportedly caused kidney failure in two women.